Results 191 to 200 of about 6,818,964 (313)

Assessment of H-index and research impact amongst academic medical oncologists in Canada. [PDF]

open access: yesFront Res Metr Anal
Whitelaw S   +4 more
europepmc   +1 more source

Harnessing the nursing and midwifery workforce to boost Australia's clinical research impact. [PDF]

open access: yesMed J Aust, 2022
Eckert M   +12 more
europepmc   +1 more source

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

open access: yesMolecular Oncology, Volume 20, Issue 6, Page 1643-1660, June 2026.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra   +6 more
wiley   +1 more source

Consider impact early

open access: yes, 2015
There is a recurring theme in the posts on this blog that relates to planning, timing and impact activity. One of the six lessons highlighted from the SCEIP project was to plan, another was to consider your audience, yet another key message is around ...
Blog Admin, LSE Social Care Research Impact Blog
core  

Pre‐analytical optimization of cell‐free DNA and extracellular vesicle‐derived DNA for mutation detection in liquid biopsies

open access: yesMolecular Oncology, EarlyView.
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen   +11 more
wiley   +1 more source

Does your surname undermine your research impact? [PDF]

open access: yesPsychon Bull Rev
Cai YL, Wong KFE, Kwong JYY.
europepmc   +1 more source

EDNRB‐dependent endothelin signaling reduces proliferation and promotes proneural‐to‐mesenchymal transition in gliomas

open access: yesMolecular Oncology, EarlyView.
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau   +36 more
wiley   +1 more source

Home - About - Disclaimer - Privacy